Cody is an EIR and was most recently Senior Director, Business Development Lead at Prime Medicine, where he focused on all aspects of business development and corporate strategy for Prime’s platform and therapeutic programs. Prior to Prime, Cody was Head of Genetic Medicines Research at Casdin Capital, where he led the firm’s public and private investments in Cell & Gene Therapy. Cody is also a Director at Cure Rare Disease, a non-profit focused on n-of-1 therapeutics. Cody graduated magna cum laude from Amherst College with a B.A. in biology and economics, and he is currently an MS/MBA Candidate at Harvard Business School and Harvard Graduate School of Arts and Sciences.